International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

No abstract is available for this paper.

• Publication year

  1999

• Venue

  American Journal of Clinical Pathology

• Publication date

  1999-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/AJCP/111.4.507PMID 10191771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

  2010cited by this paper
• Antinuclear factors in sera from healthy blood donors.

  2009cited by this paper
• Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD).

  1998cited by this paper
• A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.

  1998cited by this paper
• Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

  1998cited by this paper
• Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1.

  1997cited by this paper
• Specificities of anti‐neutrophil autoantibodies in patients with rheumatoid arthritis (RA)

  1997cited by this paper
• Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes.

  1997cited by this paper
• Novel autoantigens of perinuclear anti‐neutrophil cytoplasmic antibodies (P‐ANCA) in ulcerative colitis: non‐histone chromosomal proteins, HMG1 and HMG2

  1997cited by this paper
• Methods to detect autoantibodies to neutrophilic granulocytes

  1996cited by this paper
• Frequency of anti‐bactericidal/permeability‐increasing protein (BPI) and anti‐azurocidin in patients with renal disease

  1996cited by this paper
• The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition.

  1996cited by this paper
• Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays.

  1996cited by this paper
• Antigen specificity of antineutrophil antibodies in ulcerative colitis, primary sclerosing cholangitis and autoimmune hepatitis

  1996cited by this paper
• ANCA and predicting relapse in systemic vasculitis.

  1995cited by this paper
• Antigen specificity in hydralazine associated ANCA positive systemic vasculitis.

  1995cited by this paper
• Detection of autoantibodies to neutrophil cytoplasmic antigens.

  1995cited by this paper
• ACP Broadsheet No 143: January 1994. Detection of autoantibodies to neutrophil cytoplasmic antigens.

  1994cited by this paper
• Some patients with anti‐myeloperoxidase autoantibodies have a C‐ANCA pattern

  1994cited by this paper
• Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

  1994cited by this paper
• Neutrophil alloantibodies react with cytoplasmic antigens: a possible cause of false-positive indirect immunofluorescence assays for antibodies to neutrophil cytoplasmic antigens.

  1993cited by this paper
• The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization.

  1993cited by this paper
• Alpha-enolase: a novel cytosolic autoantigen in ANCA positive vasculitis.

  1993cited by this paper
• Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy.

  1993cited by this paper
• Autoantibodies directed against lysozyme: a new target antigen for anti-neutrophil cytoplasmic antibodies (ANCA).

  1993cited by this paper
• Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis

  1992cited by this paper
• Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective.

  1991cited by this paper
• Antineutrophil cytoplasmic autoantibody-associated diseases: a pathologist's perspective.

  1991cited by this paper
• Antineutrophil cytoplasmic antibody—A useful serological marker for vasculitis

  1991cited by this paper
• Antineutrophil cytoplasmic autoantibody-associated diseases: a pulmonologist's perspective.

  1991cited by this paper
• Anti‐neutrophil cytoplasm antibodies in rheumatoid arthritis

  1991cited by this paper
• Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis.

  1990cited by this paper
• A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease.

  1990cited by this paper
• Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

  1989cited by this paper
• Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.

  1989cited by this paper
• ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES

  1989cited by this paper
• Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase.

  1989cited by this paper
• Circulating anti-elastase in systemic lupus erythematosus.

  1989cited by this paper
• Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis.

  1989cited by this paper
• Delineation of a standard procedure for indirect immunofluorescence detection of ANCA.

  1989cited by this paper
• Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils.

  1989cited by this paper
• Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

  1988cited by this paper
• Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis.

  1987cited by this paper
• Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

  1985cited by this paper
• Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis.

  1980cited by this paper

• National recommendations of the Working group for laboratory diagnostics of autoimmune diseases of the Croatian Society of Medical Biochemistry and Laboratory Medicine: Assessment of antineutrophil cytoplasmic antibodies (ANCA)

  2025influential citation
• Reply

  2025cites this paper
• Antineutrophil Cytoplasmic Autoantibodies: Role in Diagnosis, Disease Monitoring, and Prognosis.

  2025cites this paper
• Antineutrophil cytoplasmic antibody-related vasculitis with a unique imaging presentation of organizing pneumonia: The key role of lung ultrasound

  2025cites this paper
• Methodological considerations for “Proinflammatory dietary pattern and the risk of female gout”: comment on the article by Rai et al

  2025cites this paper
• Biomarkers in ANCA associated vasculitis: clinical utility, pitfalls and their role in the outcomes assessment

  2025cites this paper
• Concurrent Anti-PR3 Immunoassay and cANCA Indirect Immunofluorescence Testing Provide Complementary Information for Clinical Laboratory Detection of Antineutrophil Cytoplasmic Antibodies.

  2025cites this paper
• HER ANTİ NÖTROFİL SİTOPLAZMİK ANTİKOR (ANCA) POZİTİFLİĞİ ROMATOLOJİK HASTALIKLA İLİŞKİLİ MİDİR?

  2025cites this paper
• Diagnostic Performance of ANCA Testing Across Three Platforms with and without Coexisting ANA Positivity: Experience from a Tertiary Healthcare Centre in India

  2025cites this paper
• Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis.

  2025cites this paper
• Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden

  2025cites this paper
• Ulcerative colitis complicated by granulomatosis with polyangiitis treated with tacrolimus.

  2025cites this paper
• Seven cases illustrating difficulties in the treatment of MPO-ANCA-positive refractory otitis media

  2024cites this paper
• Comparison of different ANCA detection methods in a predominantly MPO-ANCA-associated vasculitis cohort

  2024cites this paper
• Management of severe ANCA-associated glomerulonephritis: comparison of international recommendations and narrative review

  2024cites this paper
• Effect of antinuclear antibody positivity on antineutrophil cytoplasmic antibody results by indirect immunofluorescence assay

  2024cites this paper
• History of antineutrophil cytoplasmic autoantibodies

  2024cites this paper
• Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective.

  2024cites this paper
• Vasculites associadas aos anticorpos anticitoplasma de neutrófilos (ANCA): granulomatose com poliangiite e poliangiite microscópica

  2024cites this paper
• Performance of two multiplex flow cytometric assays for antibody detection in Egyptian patients

  2023cites this paper
• Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study

  2023cites this paper
• Overview of Vasculitides in Adults.

  2023cites this paper
• Significance of autoantibodies in diagnostics of systemic vasculitis

  2023cites this paper
• Poor Adherence to Indications for Anti-neutrophil Cytoplasmic Antibody Testing in a South African Tertiary Hospital

  2023cites this paper
• The role of serology, liver function tests and imaging in screening of primary sclerosing cholangitis: the HelPSCreen score

  2023cites this paper
• New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond

  2023cites this paper
• Interference of anti-nuclear antibodies on determination of anti-neutrophil cytoplasmic antibodies in patients suspected of vasculitis: a case series

  2023influential citation
• Verification, implementation and harmonization of automated chemiluminescent immunoassays for MPO- and PR3-ANCA detection

  2023cites this paper
• Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases

  2023cites this paper
• Autoantibodies in COVID‐19, a possible role in the pathogenesis of the disease

  2023cites this paper
• ANCA-associated vasculitis: overview and practical issues of diagnosis and therapy from a European perspective

  2023cites this paper
• The Role of Neutrophils in ANCA-Associated Vasculitis: The Pathogenic Role and Diagnostic Utility of Autoantibodies

  2023cites this paper
• Adult and childhood vasculitis.

  2023cites this paper
• Current concepts in granulomatosis poly angiitis and the eye

  2022cites this paper
• Investigation of anti-neutrophil cytoplasmic antibody presence with indirect immunofluorescence and enzyme-linked immunosorbent assay

  2022cites this paper
• The presentation, etiologies, pathophysiology, and treatment of pulmonary renal syndrome: A review of the literature.

  2022cites this paper
• Uncommon onset manifestations without renal involvement in microscopic polyangiitis: A case report

  2022cites this paper
• Interest of a Kidney Biopsy to Rule out ANCA-Associated Renal Vasculitis in Glomerulonephritis Patients with a Positive ANCA

  2022cites this paper
• Serological biomarkers for management of primary sclerosing cholangitis

  2022cites this paper
• Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective

  2022cites this paper
• Clinical, Methodological, and Practical Considerations for Algorithmic Testing in Autoimmune Serology.

  2022influential citation
• PR3-ANCAs Detected by Third-Generation ELISA Predicts Severe Disease and Poor Survival in Primary Sclerosing Cholangitis

  2022influential citation
• Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis.

  2022cites this paper
• Laboratory Diagnosis of ANCA-Associated Vasculitis (AAV) Using a Combination of Immunofluorescence Test (IIFT) and Line Immunoassay (LIA): Single-Centre Report From India.

  2022cites this paper
• ANCA testing: where are we now?

  2021cites this paper
• The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies.

  2021influential citation
• Neutrophil fixation protocols suitable for substrates to detect anti-neutrophil cytoplasmic antibodies by indirect immunofluorescence.

  2021cites this paper
• Clinical Relevance of Autoantibodies and Inflammatory Parameters in Non-infectious Scleritis

  2021cites this paper
• Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Toward an Individualized Approach

  2021cites this paper
• Utility of anti-neutrophil cytoplasmic antibody screening in idiopathic interstitial lung disease

  2021cites this paper
• Indications and diagnostic outcome of antineutrophil cytoplasmic antibody testing in hospital medicine: a pattern of over-screening

  2021cites this paper
• ANCA Testing in Clinical Practice: From Implementation to Quality Control and Harmonization

  2021influential citation
• Granulomatosis with Polyangiitis and Nasal Involvement - What Radiological Markers Point the Disease.

  2021cites this paper
• Glomerulonephritis in AKI: From Pathogenesis to Therapeutic Intervention

  2021influential citation
• Antimyeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in ANCA-associated-vasculitis.

  2021cites this paper
• Sarcoidosis and neuromyelitis optica in a patient with optic neuritis – a case report

  2021cites this paper
• Antineutrophil cytoplasmic antibody profiles differ according to type of primary sclerosing cholangitis and autoimmune hepatitis

  2021cites this paper
• Screening and Confirmatory Anti-Neutrophil Cytoplasmic Antibodies (ANCA) Testing for Rapidly Progressive Glomerulonephritis (RPGN): A Tertiary Care Experience

  2021cites this paper
• A Comparative Evaluation of Antigen-Specific Sandwich Immunoassay and Indirect Immunofluorescence Assay (IIF) in Detecting Antineutrophil Cytoplasmic Antibodies: Are We Ready to Replace IIF with ELISA as the Primary Screening Method?

  2021cites this paper
• Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis

  2020cites this paper
• The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis.

  2020cites this paper
• Perinuclear anti-neutrophil cytoplasmic antibody in systemic lupus erythematosus indicates more severe condition.

  2020cites this paper
• Drug-induced cutaneous vasculitis and anticoagulant-related cutaneous adverse reactions: insights in pathogenesis, clinical presentation, and treatment.

  2020cites this paper
• Laboratory Diagnosis of ANCA-Associated Vasculitis (AAV) Using a Combination of Immunofluorescence Test (IIFT) and Line Immunoassay (LIA): Single-Centre Report From India.

  2020cites this paper
• IMMUNODIAGNOSIS IN MEMBRANOUS NEPHROPATHY.

  2020cites this paper
• Anti-neutrophil cytoplasmic antibody testing by indirect immunofluorescence: Computer-aided versus conventional microscopic evaluation of routine diagnostic samples from patients with vasculitis or other inflammatory diseases.

  2020cites this paper
• Autoantibody Assays: Performance, Interpretation, and Standardization

  2020cites this paper
• Clinical implications of ANCA positivity in a hospital setting: a tertiary center experience

  2020cites this paper
• 2020 international consensus on ANCA testing beyond systemic vasculitis.

  2020cites this paper
• ANCA-Diagnostik bei Vaskulitiden

  2020cites this paper
• Antineutrophil cytoplasmic antibodies (ANCA) – their role in pathogenesis, diagnosis, and treatment monitoring of ANCA-associated vasculitis

  2020cites this paper
• [Chances and Pitfalls of ANA and ANCA Diagnostics].

  2020cites this paper
• A Case Report of Phenytoin-Induced Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

  2020cites this paper
• Serological testing in small vessel vasculitis.

  2020cites this paper
• Relapse rate and renal prognosis in ANCA‐associated vasculitis according to long‐term ANCA patterns

  2020cites this paper
• Granulomatosis with polyangiitis

  2020cites this paper
• Necrotizing Arteritis and Small-Vessel Vasculitis

  2020cites this paper
• ANCA-associated vasculitis

  2020cites this paper
• Autoantibody Biomarkers in Rheumatic Diseases

  2020influential citation
• Tofacitinib suppressed remodeling of pulmonary eosinophilic vasculitis in a murine model

  2020cites this paper
• Induction of hemodialysis with an arteriovenous fistula in a patient with hemophilia A

  2020cites this paper
• Frequency of positive ANCA test in a population with clinical symptoms suggestive of autoimmune disease and the interference of ANA in its interpretation

  2020cites this paper
• The perspective on standardisation and harmonisation: the viewpoint of the EASI president

  2020cites this paper
• Frequency of Positive ANCA Test in a Population With Clinical Symptoms Suggestive of Autoimmune Disease and the Interference of ANA in its Interpretation.

  2020cites this paper
• TRAb measurement: evaluation of the cut-off value RFA for hyperactive thyroid adenoma A Dutch consensus on AAV diagnosis and treatment Type I cryoglobulinaemic vasculitis

  2020cites this paper
• Antineutrophil Cytoplasmic Antibodies Testing and Interpretation.

  2019cites this paper
• Peripheral Nerve Vasculitis: Classification and Disease Associations.

  2019cites this paper
• ANCA: Methods and Clinical Significance

  2019cites this paper
• A Dutch consensus statement on the diagnosis and treatment of ANCA-associated vasculitis.

  2019cites this paper
• Autoantikörper gegen Proteinase 3

  2019cites this paper
• PtCo nanocubes/reduced graphene oxide hybrids and hybridization chain reaction-based dual amplified electrochemiluminescence immunosensing of antimyeloperoxidase.

  2019cites this paper
• Evaluation of 12 different assays for detecting ANCA in Chinese patients with GPA and MPA: a multicenter study in China

  2019cites this paper
• OP-BRHE180325 656..671 ++

  2019cites this paper
• The Diagnostic and Clinical Utility of Autoantibodies in Systemic Vasculitis

  2019cites this paper
• Classification of Antineutrophil Cytoplasmic Antibody-associated Vasculitis

  2019cites this paper
• "Fleshy" Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis.

  2019cites this paper
• A Case Report of Multiple Myeloma Associated With Myeloperoxidase and Proteinase-3 Antibodies Posing a Diagnostic Dilemma

  2019cites this paper
• Laboratory tests in rheumatology: A rational approach

  2019cites this paper
• Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?

  2019cites this paper
• Interpretation of autoantibodies in rheumatological diseases (cid:2)

  2019cites this paper